Hypercalcemia Of Malignancy
Hypercalcemia of Malignancy is a pathological condition characterized by elevated serum calcium levels resulting from tumor-induced mechanisms, most commonly mediated by osteolytic bone metastases or humoral factors such as parathyroid hormone-related protein.
1K
Publications
49.3K
Citations
3.7K
Authors
913
Institutions
Publications per year
2017–2026
41
Parents
1K
Pierre Major, Alain Lortholary, Jeremy K. Hon et al. · Journal of Clinical Oncology · 2001 · 857 citations
1–5 of 1K
3.7K
28
h-index
The University of Texas at San Antonio Health Science Center, United States
25 publications · 1.8K citations
22
h-index
19
h-index
18
h-index
16
h-index
1–5 of 3.7K
913
Yale University
New Haven, United States
28 h-index
191 publications
17.3K citations

The University of Texas at San Antonio Health Science Center
San Antonio, United States
23 h-index
64 publications
4.7K citations
United States Department of Veterans Affairs
Washington, United States
18 h-index
85 publications
8.9K citations
The Ohio State University
Columbus, United States
16 h-index
94 publications
4.2K citations
Memorial Sloan Kettering Cancer Center
New York, United States
15 h-index
55 publications
2.9K citations
VA Connecticut Research and Education Foundation
West Haven, United States
15 h-index
90 publications
13.9K citations
Harvard University
Cambridge, United States
15 h-index
53 publications
4.4K citations

McGill University
Montreal, Canada
15 h-index
43 publications
4.3K citations
1–8 of 913
Repository · 128 publications · 4.5K citations
36
h-index
JCEM · 65 publications · 4K citations
36
h-index
61 publications · 2.9K citations
32
h-index
36 publications · 1.6K citations
24
h-index
JBMR · 28 publications · 1.4K citations
22
h-index
1–5